热门资讯> 正文
Sanuwave通过新的信贷安排对债务进行再融资
2025-09-26 22:46
- Sanuwave Health (NASDAQ:SNWV) has announced the refinancing of its $27.5M debt facility with a $23.0M new secured credit facility from J.P. Morgan, 1.0M withdrawn from a two-year $5.0M revolving credit facility, and the remainder was repaid using cash accumulated from the company’s operations and from its sale of certain intravascular shockwave patents.
- The $23.0M loan will amortize over a four-year period, and a two-year $5.0M receivables are backed by a revolving credit facility.
- The new credit facility will have an interest rate of SOFR (Secured Overnight Financing Rate) +350bp and neither facility has any prepayment penalties.
More on SANUWAVE Health
- Sanuwave: A Long-Term Compounder In Its Early Stages
- SANUWAVE Health, Inc. 2025 Q2 - Results - Earnings Call Presentation
- SANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call Transcript
- Sanuwave Health rises after $5M payment related to patent sale
- SANUWAVE outlines Q3 revenue target of $12M–$12.7M as new applicator production nears launch
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。